Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
5,856
datasets available to search
ShareScore release 0.9.0
Dataset results
5,856 results for “B cells”
DZD8586 Combination Therapy in Patients With Diffuse Large B-cell Lymphoma (TAI-SHAN12)
ClinicalTrials.gov study NCT07059650. IPD Sharing: NO. Countries: 1. Publications: 0.
Human Tumor Necrosis Factor Alpha (TNFa)-Induced Pre-B Cell Bone Marrow Emigrants
ClinicalTrials.gov study NCT01009879. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Procurement of Follicular B Cell Lymphoma Cells for the Purpose of Possible Use in Future Clinical Trials
ClinicalTrials.gov study NCT00487513. IPD Sharing: Not stated. Countries: 1. Publications: 0.
P-CD19CD20-ALLO1 Allogeneic CAR-T Cells in the Treatment of Subjects With B Cell Malignancies
ClinicalTrials.gov study NCT06014762. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Effect of Telitacicept on Transitional Regulatory B Cells in Patients With Systemic Lupus Erythematosus
ClinicalTrials.gov study NCT06137053. IPD Sharing: Not stated. Countries: 1. Publications: 0.
B Cell Repertoires in Chronic Lymphocytic Leukemia and Aging
ClinicalTrials.gov study NCT01028430. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Avelumab, Utomilumab, Rituximab, Ibrutinib, and Combination Chemotherapy in Treating Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma or Mantle Cell Lymphoma
ClinicalTrials.gov study NCT03440567. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study to Evaluate the Effectiveness and Safety of Polatuzumab in Real World Clinical Practice Among Adult Chinese Participants With Diffuse Large B-Cell Lymphoma
ClinicalTrials.gov study NCT05954910. IPD Sharing: YES. Countries: 1. Publications: 0.
To Evaluate Safety and Efficacy of Autologous CD19 Chimeric Antigen Receptor (CAR)-T Cells in Relapsed/Refractory B- Non-Hodgkin Lymphoma (B-NHL)
ClinicalTrials.gov study NCT06698484. IPD Sharing: NO. Countries: 1. Publications: 0.
Axicabtagene Ciloleucel CAR T-cells in Patients With Relapsed or Refractory Primary Mediastinal B-cell Lymphoma
ClinicalTrials.gov study NCT06912529. IPD Sharing: NO. Countries: 1. Publications: 0.
Treatment of Multiple Sclerosis and Neuromyelitis Optica With Regulatory Dendritic Cell: Clinical Trial Phase 1 B
ClinicalTrials.gov study NCT02283671. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Loncastuximab and Roflumilast Added to R-CHOP (Lo-(Rituximab and Roflumilast) RR-CHOP) for Naïve High-Risk Diffuse Large B-cell Lymphoma (DLBCL)
ClinicalTrials.gov study NCT06977711. IPD Sharing: YES. Countries: 1. Publications: 0.
A Clinical Research of BCMA-Targeted CAR-T in B Cell Malignancies
ClinicalTrials.gov study NCT02954445. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
RESEARCH ON FACTORS OF RESISTANCE TO CHEMOTHERAPY AND INNOVATIVE THERAPIES IN MATURE B-CELL LYMPHOIDS
ClinicalTrials.gov study NCT07385612. IPD Sharing: NO. Countries: 1. Publications: 0.
Real-World Clinical Outcomes in Adult Patients Who Initiate Systemic Treatment for Relapsed/Refractory Diffuse Large B-Cell Lymphoma
ClinicalTrials.gov study NCT05338892. IPD Sharing: NO. Countries: 4. Publications: 0.
GB5005 CART-cell Injection in the Treatment of Patients With CD19-positive RR B-NHL
ClinicalTrials.gov study NCT06875063. IPD Sharing: NO. Countries: 1. Publications: 0.
Improving the Outcome of High-risk Aggressive B-cell Lymphoma Patients With Nivolumab Maintenance Therapy
ClinicalTrials.gov study NCT03569696. IPD Sharing: NO. Countries: 1. Publications: 0.
B-catenin in Cutaneous Squamous Cell Carcinoma and Its Mimickers
ClinicalTrials.gov study NCT06536946. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Relmacabtagene Autoleucel Combined With Sintilimab for Relapsed/Refractory B-cell Lymphoma
ClinicalTrials.gov study NCT07077512. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
A Study to Investigate Safety of INT2104 Infusions in Participants Aged 18 Years of Age and Older Who Have B-cell Cancers That Came Back After Previous Treatment
ClinicalTrials.gov study NCT06539338. IPD Sharing: Not stated. Countries: 2. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.